XML 25 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).
The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements within the Annual Report on Form 10-K for the year ended December 31, 2025.
The compensation cost charged against income from those plans is included in selling, general & administrative expenses as follows (in thousands):
Three Months EndedSix Months Ended
June 30,June 30,
Share-based compensation related to:2026202520262025
Restricted Stock Unit Awards ("RSUs")$3,024 $2,120 $5,557 $4,124 
Common stock grants200 100 400 200 
Stock option grants— 65 — 173 
Total share-based compensation$3,224 $2,285 $5,957 $4,497 
The total income tax benefit recognized in the condensed consolidated statements of comprehensive income for share-based compensation arrangements was approximately $1.0 million and $1.9 million for the three and six months ended June 30, 2026, respectively, and approximately $0.8 million and $2.0 million for the three and six months ended June 30, 2025.
Common Stock Grants
The compensation expense for common stock granted during the six months ended June 30, 2026, was determined based on the market price of the shares on the date of grant.
Stock Option Grants
The following is a summary of stock option activity under all plans for the six months ended June 30, 2026:
Shares Under OptionsWeighted Average Exercise Price (per share)Weighted Average Remaining Contractual Life (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202561,969$72.80 
Exercised(6,928)25.81 
Outstanding at June 30, 202655,041$78.72 3.97$10,260 
Exercisable at June 30, 202655,041$78.72 3.97$10,260 
Vested and expected to vest at June 30, 202655,041$78.72 3.97$10,260 
During the six months ended June 30, 2026 and 2025, the total intrinsic value of all options exercised (i.e., the difference between the market price and the price paid by the employees to exercise the options) was approximately $1.7 million and $2.2 million, respectively, and the total amount of consideration received by the Company from the exercised options was approximately $0.2 million and $0.4 million, respectively. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the six months ended June 30, 2026, no shares were surrendered. During the six months ended June 30, 2025, 748 shares were surrendered at an average market price of $282.42.
Restricted Stock Unit awards
The following table summarizes information about RSU activity during the six months ended June 30, 2026:
Restricted Stock UnitsWeighted Average
 Grant Date
 Fair Value
Outstanding at December 31, 202579,601 $175.06 
Awarded58,169 256.42 
Shares vested(41,965)186.23 
Shares forfeited(567)231.03 
Outstanding at June 30, 202695,238 $219.49 
At the Company’s discretion, upon vesting, RSU holders are given the option to net-share settle to cover the required minimum withholding tax and the remaining amount is converted into the equivalent number of common shares and issued to the RSU holder. During the six months ended June 30, 2026 and 2025, 17,440 and 18,152 shares were surrendered at an average market price of $204.76 and $215.60, respectively.
As of June 30, 2026, the Company had approximately $15.0 million of unrecognized compensation expense that is expected to be recognized over a period of 2.75 years.